NanoString Technologies Stock Forecast, Price & News

-0.18 (-0.29 %)
(As of 07/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume268,016 shs
Average Volume572,460 shs
Market Capitalization$2.76 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NSTG News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoString Technologies and its competitors with MarketBeat's FREE daily newsletter.

NanoString Technologies logo

About NanoString Technologies

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq technologies. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; and Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.13 out of 5 stars

Medical Sector

2147th out of 4,434 stocks

Biological Products, Except Diagnostic Industry

297th out of 422 stocks

Analyst Opinion: 2.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions

Is NanoString Technologies a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NanoString Technologies stock.
View analyst ratings for NanoString Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than NanoString Technologies?

Wall Street analysts have given NanoString Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but NanoString Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is NanoString Technologies' next earnings date?

NanoString Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for NanoString Technologies

How can I listen to NanoString Technologies' earnings call?

NanoString Technologies will be holding an earnings conference call on Wednesday, August 4th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 416-621-4642 with passcode "3414117".

How were NanoString Technologies' earnings last quarter?

NanoString Technologies, Inc. (NASDAQ:NSTG) issued its earnings results on Monday, May, 10th. The biotechnology company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.58) by $0.04. The biotechnology company had revenue of $31.60 million for the quarter, compared to analyst estimates of $30.51 million. NanoString Technologies had a negative net margin of 81.07% and a negative trailing twelve-month return on equity of 52.15%. The business's revenue was up 18.8% on a year-over-year basis.
View NanoString Technologies' earnings history

How has NanoString Technologies' stock price been impacted by Coronavirus (COVID-19)?

NanoString Technologies' stock was trading at $30.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NSTG stock has increased by 100.1% and is now trading at $61.04.
View which stocks have been most impacted by COVID-19

What price target have analysts set for NSTG?

5 Wall Street analysts have issued twelve-month target prices for NanoString Technologies' stock. Their forecasts range from $40.00 to $80.00. On average, they anticipate NanoString Technologies' share price to reach $67.60 in the next twelve months. This suggests a possible upside of 10.7% from the stock's current price.
View analysts' price targets for NanoString Technologies
or view top-rated stocks among Wall Street analysts.

Who are NanoString Technologies' key executives?

NanoString Technologies' management team includes the following people:
  • Mr. R. Bradley Gray, CEO, Pres & Director (Age 44, Pay $1.14M)
  • Mr. K. Thomas Bailey M.B.A., Chief Financial Officer (Age 52, Pay $638.16k)
  • Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 54, Pay $598.61k)
  • Mr. J. Chad Brown, Sr. VP of Sales & Marketing (Age 63, Pay $612.99k)
  • Dr. Joseph M. Beechem, Chief Scientific Officer and Sr. VP of R&D (Age 63, Pay $615.92k)
  • Mr. Mark A. Winham, Sr. VP of Operations
  • Mr. Douglas S. Farrell, VP of Investor Relations & Corp. Communications
  • Ms. Kathryn Surace-Smith, Sr. VP of HR & Legal Affairs and Corp. Sec. (Age 62)
  • Dr. Mary Tedd Allen, Sr. VP of Strategic Initiatives (Age 58)
  • Dr. Philippa Webster Ph.D., Sr. Principal Scientist

What is Brad Gray's approval rating as NanoString Technologies' CEO?

36 employees have rated NanoString Technologies CEO Brad Gray on Brad Gray has an approval rating of 65% among NanoString Technologies' employees.

Who are some of NanoString Technologies' key competitors?

What other stocks do shareholders of NanoString Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling (PD), AutoZone (AZO), Designer Brands (DBI), Bank of the Ozarks (OZRK) and Vista Outdoor (VSTO).

What is NanoString Technologies' stock symbol?

NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."

Who are NanoString Technologies' major shareholders?

NanoString Technologies' stock is owned by a variety of retail and institutional investors. Top institutional investors include Harel Insurance Investments & Financial Services Ltd. (0.01%). Company insiders that own NanoString Technologies stock include Charles P Waite Jr, Charles P Waite, Jr, David W Ghesquiere, Elisha W Finney, Gregory Norden, J Chad Brown, Joseph M Beechem, K Thomas Bailey, Kirk Malloy, R Bradley Gray, Robert Hershberg and William Young.
View institutional ownership trends for NanoString Technologies

Which major investors are selling NanoString Technologies stock?

NSTG stock was sold by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd.. Company insiders that have sold NanoString Technologies company stock in the last year include Charles P Waite Jr, Elisha W Finney, Gregory Norden, J Chad Brown, Joseph M Beechem, K Thomas Bailey, Kirk Malloy, R Bradley Gray, and Robert Hershberg.
View insider buying and selling activity for NanoString Technologies
or view top insider-selling stocks.

How do I buy shares of NanoString Technologies?

Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoString Technologies' stock price today?

One share of NSTG stock can currently be purchased for approximately $61.04.

How much money does NanoString Technologies make?

NanoString Technologies has a market capitalization of $2.76 billion and generates $117.32 million in revenue each year. The biotechnology company earns $-110,080,000.00 in net income (profit) each year or ($2.82) on an earnings per share basis.

How many employees does NanoString Technologies have?

NanoString Technologies employs 579 workers across the globe.

What is NanoString Technologies' official website?

The official website for NanoString Technologies is

Where are NanoString Technologies' headquarters?

NanoString Technologies is headquartered at 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109.

How can I contact NanoString Technologies?

NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at [email protected]

This page was last updated on 7/27/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.